Stuart Raetzman Appointed CEO of Nestlé Skin Health
Nestlé has appointed Stuart Raetzman as CEO of Nestlé Skin Health, effective immediately.
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170522005484/en/
“I am very pleased that Stuart will be leading Nestlé Skin Health as CEO. Nestlé’s purpose is to enhance quality of life and contribute to a healthier future. Under Stuart’s leadership, Nestle Skin Health will support our overall mission,” says Mark Schneider, CEO of Nestlé.
Stuart is a healthcare professional with over 25 years’ experience. He previously held senior executive positions with several healthcare companies and has worked across a wide spectrum of healthcare categories including pharmaceuticals, biologics, disposable and implantable medical devices, capital equipment and consumer products. Stuart joined the company in 2014 as President, North America. In 2015, he moved to Nestlé Skin Health’s global headquarters in Lausanne.
“I am truly honored to lead Nestlé Skin Health. It’s a great company, with a rich portfolio of prescription, consumer and aesthetic and corrective products, and employees who are passionate about skin health. Galderma, which is a wholly-owned subsidiary of Nestlé Skin Health, focuses on the partnership with healthcare professionals. Moving forward, we will renew this commitment to helping healthcare professionals and also the patients they serve, by providing them with innovative solutions to meet their skin health needs,” says Stuart Raetzman.
About Nestlé Skin Health
Nestlé Skin Health’s mission is to enhance quality of life by delivering science-based solutions for the health of skin, hair and nails. As one of the category’s leading companies, Nestlé Skin Health conducts ground-breaking product research to provide both the healthcare community and the consumer with an ongoing progression of innovative technologies and products to protect, serve and enhance skin health. For more information, please visit www.nestleskinhealth.com
Nestlé Skin Health
Yvan Deurbroeck, Mobile phone: +41792543824
Global Vice-President Communications, Digital and Congresses
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Skriv dig op her og modtag pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Business Wire
DE-INCYTE21.10.2018 12:47 | pressemeddelelse
Incyte Announces Positive Interim Data from Phase 2 Trial of Pemigatinib, Its Selective FGFR Inhibitor, in Patients with Cholangiocarcinoma
SERVIER21.10.2018 11:12 | pressemeddelelse
Servier and Taiho Oncology Announce Phase III LONSURF® Study Has Met Primary and Secondary Endpoints Demonstrating Prolonged Overall Survival and Progression-Free Survival in Patients with Refractory Metastatic Gastric Cancer
IL-GILEAD-SCIENCES21.10.2018 00:32 | pressemeddelelse
Phase 3 Data on Filgotinib in Biologic-Experienced Rheumatoid Arthritis to Be Presented at 2018 ACR/ARHP Annual Meeting
CA-TRUE-RELIGION19.10.2018 19:39 | pressemeddelelse
Manchester United and True Religion Launch Denim Range
ARCH-INSURANCE19.10.2018 15:12 | pressemeddelelse
Arch Insurance Announces Strategic Leadership Changes
MA-TAKEDA-PHARMACEUTICAL19.10.2018 14:02 | pressemeddelelse
Takeda to Present Results from Phase 3 ALTA-1L Trial Highlighting Intracranial Efficacy of ALUNBRIG® (brigatinib) Versus Crizotinib in First-Line Advanced ALK+ Non-Small Cell Lung Cancer
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum